Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect

Manabu Uematsu (Fukushima, Japan), Manabu Uematsu, Junpei Saito, Suguru Sato, Atsuro Fukuhara, Yasuhito Suzuki, Ryuichi Togawa, Yuki Sato, Kenichi Misa, Takefumi Nikaido, Naoko Fukuhara, Xintao Wang, Yoshinori Tanino, Mitsuru Munakata

Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Session: Pharmacological intervention in humans and murine models of asthma
Session type: Thematic Poster
Number: 1114
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Manabu Uematsu (Fukushima, Japan), Manabu Uematsu, Junpei Saito, Suguru Sato, Atsuro Fukuhara, Yasuhito Suzuki, Ryuichi Togawa, Yuki Sato, Kenichi Misa, Takefumi Nikaido, Naoko Fukuhara, Xintao Wang, Yoshinori Tanino, Mitsuru Munakata. Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect. Eur Respir J 2016; 48: Suppl. 60, 1114

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Effect of environmental pollution on the control of bronchial asthma and fractional exhaled nitric oxide (FeNO)
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013


Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma
Source: Annual Congress 2013 –Asthma
Year: 2013


Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016



The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Effect of spirometry and bronchodilation test in eNO levels
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016